反应性氧物种-响应性聚合物药物输送系统向氧化应激结肠细胞,以改善结肠炎
Wo-Qi Cai1,2,3, Wanqi Liang1,2,3, Dong Li4
1Department of Biology, College of Science, Shantou University, Shantou 515063, Guangdong, China.
ACS nano
|April 30, 2025
概括
这项研究开发了新的纳米颗粒,用于为性结肠炎 (UC) 治疗提供素. 这些向的纳米粒子减少炎症并恢复肠道健康,为UC患者提供了有前途的治疗方法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米医学是一种纳米医学.
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种具有重大全球健康影响的慢性炎症性肠病.
- 炎症的结肠表现出高反应性氧物种 (ROS),障碍障碍和不良生物微生物组.
- 目前的UC治疗在向性交付和有效性方面面临挑战.
研究的目的:
- 设计和评估一种新型的ROS响应纳米载体,用于在UC治疗中准黄素的输送.
- 为了利用炎症结肠的独特微环境,增强治疗积累.
- 为了研究这种纳米载体系统减轻UC症状的潜力.
主要方法:
- 制造负电荷,二化物键修饰的素甲基纤维素 (CMC) 纳米颗粒封装黄素.
- 纳米粒子稳定性,ROS响应释放和细胞相互作用的体外和体外评估.
- 在UC模型中评估治疗疗效,重点关注炎症,屏障功能和肠道微生物群调节.
主要成果:
- 开发的纳米颗粒有效地稳定了黄素,并证明了ROS在炎症部位的释放.
- 纳米颗粒通过与过度表达的叶酸受体相互作用,在结肠炎组织中呈现出增强的积累.
- 用纳米颗粒治疗导致ROS清理,恢复肠道屏障完整性和肠道微生物群调节.
- 在预防和治疗环境中观察到UC症状的显著缓解.
结论:
- 设计的纳米载体系统为UC治疗提供了曲素的有针对性和响应性.
- 这种方法有效地解决了UC的关键病理特征,包括氧化应激和屏障功能障碍.
- 这项研究表明,治疗性结肠炎的新治疗策略是有希望的.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
109
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
109
01:19Phase I Oxidative Reactions: Overview
215
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
215